An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai
Currently, there is no treatment that slows the progression of the disease, which is the leading cause of vision loss in people over 65.
“This is the first study to show preservation of vision after a single injection of adult-derived human cells into a rat model with age-related macular degeneration,” said Shaomei Wang, MD, PhD, lead author of the study published in the journal STEM CELLS and a research scientist in the Eye Program at the Cedars-Sinai Board of Governors Regenerative Medicine Institute.
The stem cell injection resulted in 130 days of preserved vision in laboratory rats, which roughly equates to 16 years in humans.
Age-related macular degeneration affects upward of 15 million Americans. It occurs when the small central portion of the retina, known as the macula, deteriorates. The retina is the light-sensing nerve tissue at the back of the eye. Macular degeneration may also be caused by environmental factors, aging and a genetic predisposition.
When animal models with macular degeneration were injected with induced neural progenitor stem cells, which derive from the more commonly known induced pluripotent stem cells, healthy cells began to migrate around the retina and formed a protective layer. This protective layer prevented ongoing degeneration of the vital retinal cells responsible for vision.
Cedars-Sinai researchers in the Induced Pluripotent Stem Cell (iPSC) Core, directed by Dhruv Sareen, PhD, with support from the David and Janet Polak Foundation Stem Cell Core Laboratory, first converted adult human skin cells into powerful induced pluripotent stem cells (iPSC), which can be expanded indefinitely and then made into any cell of the human body. In this study, these induced pluripotent stem cells were then directed toward a neural progenitor cell fate, known as induced neural progenitor stem cells, or iNPCs.
“These induced neural progenitor stem cells are a novel source of adult-derived cells which should have powerful effects on slowing down vision loss associated with macular degeneration,” said Clive Svendsen, PhD, director of the Board of Governors Regenerative Medicine Institute and contributing author to the study. “Though additional pre-clinical data is needed, our institute is close to a time when we can offer adult stem cells as a promising source for personalized therapies for this and other human diseases.”
The Latest on: Age-Related Macular Degeneration
via Google News
The Latest on: Age-Related Macular Degeneration
- Predictors of Macular Degeneration Include Alcohol, Smokingon November 30, 2021 at 11:42 am
Smoking or consuming alcohol was causally linked with an increased risk of advanced age-related macular degeneration, while smoking cessation decreased the risk of developing advanced AMD.
- Focus on Eyes: Know the signs of age-related macular degenerationon November 23, 2021 at 2:40 am
Age-related macular degeneration is a disease of the macula that results in difficulty with reading, driving and recognizing objects and faces.
- Neovascular Age-Related Macular Degenerationon November 13, 2021 at 4:00 pm
A randomized clinical trial, part of the Age-Related Eye Disease Study (AREDS) and led by the National Eye Institute, was conducted in order to try to evaluate the effect of antioxidants and zinc ...
- Age-related macular degeneration Industry – Treatment, Outlook, Analysis, Research, Review to 2023on November 11, 2021 at 4:00 pm
Age-Related Macular Degeneration (AMD) is a condition that affects the back of the eye called the macula. AMD is described as either dry or wet AMD. Age-related macular degeneration causes ...
- Smoking, alcohol intake tied to age-related macular degenerationon November 10, 2021 at 8:26 am
(HealthDay)—Genetically predicted smoking initiation and lifetime smoking are associated with elevated risk of advanced age-related macular degeneration (AMD), while genetically predicted alcohol ...
- Repurposing drugs to treat age-related macular degenerationon November 8, 2021 at 4:00 pm
Researchers found that the antidepressant fluoxetine blocks the inflammation that leads to dry age-related macular degeneration (AMD), a common cause of vision loss. Health insurance data showed that ...
- Age-Related Macular Degeneration Market 2021 Growth, Industry Trend, Sales Revenue, Size by Regional Forecast to 2030on November 7, 2021 at 6:13 pm
Nov 08, 2021 (AmericaNewsHour) -- In a recent published report, Kenneth Research has updated the market report for Age-Related Macular Degeneration Market for 2021 till 2030. Report further now ...
- Neovascular age-related macular degeneration and its associated progressive vision loss cannot be reversed but it can be treatedon November 5, 2021 at 9:01 pm
Age-related macular degeneration (AMD) is a disease that can lead to progressive loss of central vision. It was estimated that in 2019 more than 2.5 million Canadians were living with AMD ...
- Age-related macular degeneration: Dry typeon November 4, 2021 at 4:14 am
Age-related macular degeneration (AMD) is a condition that causes progressive vision loss. Dry AMD is a subtype, and it typically progresses more slowly than wet AMD. The cause of dry AMD is ...
- Age-related macular degeneration Market Size 2021–Global Industry Analysis, Trends, Market Demand, Growth, Opportunities and Forecast 2023on November 2, 2021 at 8:09 pm
Global Age-related macular degeneration Market Report offers an In-Depth Top to Bottom view regarding the competitive landscape of the Age-related macular degeneration market and includes a deep ...
via Bing News